Dapagliflozin Plus Metformin Versus Metformin Alone in Overweight and Obese Patients with Polycystic Ovary Syndrome - An Open-Label, Parallel, Randomized Controlled Trial

Introduction: Insulin resistance plays the central role in the pathophysiology of polycystic ovary syndrome (PCOS). While metformin is widely used, its metabolic and androgen-lowering benefits are modest and often limited by tolerability, highlighting the need to evaluate newer therapeutic agents ta...

Cijeli opis

Bibliografski detalji

Glavni autori:	Vishal Agarwal, Sambit Das, Arun K. Choudhury, Dayanidhi Meher, Devadarshini Sahoo, Sandeep K. Sahu, Subhadra Priyadarshini, Sonam J. Agarwal, Binod Prusty, Bijay K. Das, Amogh S. Chappalagavi, Sheenam Gupta
Format:	Artigo
Jezik:	Inglês
Izdano:	Wolters Kluwer Medknow Publications 2026-01-01
Serija:	Indian Journal of Endocrinology and Metabolism
Teme:	dapagliflozin hyperandrogenism metformin polycystic ovary syndrome sglt-2 inhibitors
Online pristup:	https://journals.lww.com/10.4103/ijem.ijem_635_25
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!